Then, we constructed recombinant plasmids consisting of the C‐terminal domains of both Dnmt1 and Dnmt3a methyltransferases fused to a zinc finger domain that specifically bind to PD‐L1 promoter of prostate cancer cell line DU145. Here, DNMT3A is linked to prostate carcinoma.